Duke University Medical Center - Duke Cancer Centre is a clinical research site located in Durham, North Carolina, United States 27710.
Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.
Duke University Medical Center - Duke Cancer Centre has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer.
Sponsors: Astellas Pharma Global Development, Inc..
Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Duke University Medical Center - Duke Cancer Centre has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Duke University Medical Center - Duke Cancer Centre has 1 clinical trials on record, with 1 currently active. Their work covers Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer.
Duke University Medical Center - Duke Cancer Centre has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.